EDC Policy Communications Archive
2017
- Endocrine Society Endorsement of the Personal Care Products Safety Act | September 27, 2017
- Endocrine Society Comments on EFSA Revised BPA Review Protocol | August 24, 2017
- Joint Letter from Endocrine Society, ESE, and ESPE Regarding EDC Criteria Implementation | July 11, 2017
- Joint Letter to EU Member State Ministers Regarding the EDC Criteria | June 15, 2017
- Endocrine Society Comments on EFSA Draft Guidance on Establishing Biological Relevance | April 28, 2017
- Endocrine Society Letter to European Commission President Juncker and First Vice President Timmermans Regarding EDC Criteria Proposal | April 2, 2017
- Endocrine Society Comments on New Chemicals Review Program | January 17, 2017
2016
- Endocrine Society Comments to EPA on Draft Risk Assessment for Atrazine | October 3, 2016
- Sign-On Letter to Senate HELP Committee Leadership in Support of the Personal Care Products Safety Act | August 30, 2016
- Endocrine Society Comments to EPA on Risk Evaluation and Chemical Prioritization | August 22, 2016
- Endocrine Society Response to European Commission Proposed Criteria on EDCs | July 27, 2016
- Endocrine Society Response to FDA Petition on Phthalates | July 14, 2016
